CytoDyn (CYDY) Other Accumulated Expenses (2020 - 2025)
CytoDyn (CYDY) posted Other Accumulated Expenses of $6000.0 for Q4 2025, down 86.67% on a QoQ basis from $45000.0 in Q3 2025, and down 95.77% year-over-year from $142000.0 in Q4 2024.
CytoDyn (CYDY) Other Accumulated Expenses (2020 - 2025) Analysis & Trends
CytoDyn's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $6000.0 for Q4 2025.
- Quarterly Other Accumulated Expenses fell 95.77% year-over-year to $6000.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $6000.0 (down 95.77% YoY) and the FY2025 annual result came in at $145000.0, up 480.0% from the prior year.
- Other Accumulated Expenses was $6000.0 for Q4 2025 at CytoDyn, down from $45000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $4.7 million in Q3 2021 and bottomed at $3000.0 in Q3 2023.
- A 5-year average of $1.2 million and a median of $142000.0 in 2024 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses plunged 99.34% — and 2024, when it jumped 4633.33%.
- CytoDyn's Other Accumulated Expenses stood at $4.5 million in 2021, then slumped by 95.51% to $200000.0 in 2022, then plunged by 98.5% to $3000.0 in 2023, then soared by 4633.33% to $142000.0 in 2024, then plunged by 95.77% to $6000.0 in 2025.
- Business Quant data shows CYDY's Other Accumulated Expenses at $6000.0 in Q4 2025, $45000.0 in Q3 2025, and $145000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn |
| 10 | CytoDyn | 261.29 Mn | 261.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 6,000.00 |
| Aug 31, 2025 | 45,000.00 |
| May 31, 2025 | 145,000.00 |
| Feb 28, 2025 | 201,000.00 |
| Nov 30, 2024 | 142,000.00 |
| Aug 31, 2024 | 142,000.00 |
| May 31, 2024 | 25,000.00 |
| Aug 31, 2023 | 3,000.00 |
| Feb 28, 2023 | 30,000.00 |
| Nov 30, 2022 | 200,000.00 |
| May 31, 2022 | 64,000.00 |
| Feb 28, 2022 | 4.52 Mn |
| Nov 30, 2021 | 4.46 Mn |
| Aug 31, 2021 | 4.72 Mn |
| May 31, 2021 | 2.60 Mn |
| May 31, 2020 | 4.76 Mn |